DIA vs RLYB
DIA (DIA) versus Rallybio Corp (RLYB) — a side-by-side from cached financials, not a winner call.
DIA (DIA) common stock.
Rallybio Corp (RLYB) is a biotechnology company listed on US.
DIA does not have a complete income-statement cache yet.
Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.
DIA currently screens at market cap $0. RLYB currently screens at market cap $13.8M.
Not investment advice. Open the DIA and RLYB stock pages for the full models.
Not investment advice.